99% Purity Anti-Epileptic Levetiracetam Pharmaceutical Raw Material Levetiracetam Powder Capsule Levetiracetam

China 99% Purity Anti-Epileptic Levetiracetam Pharmaceutical Raw Material Levetiracetam Powder Capsule Levetiracetam, Find details about China Levetiracetam, Purity Levetiracetam from 99% Purity Anti-Epileptic Levetiracetam Pharmaceutical Raw Material Levetiracetam Powder Capsule Levetiracetam

Basic Info.

Model NO.

D-Sung Levetiracetam

Product Name

Levetiracetam

Name

Levetiracetam Powder

Appearance

White Powder

Color

White

Store

Cool and Dry

Grade

Pharmaceutical Grade

Assay

HPLC 99%

Application

Anthelmintics

Specific

COA

Test Method

HPLC

Shelf Life

2 Years

CAS No.

102767-28-2

Molecular Formual

C8h14n2o2

Melting Point

118-119 C

Density

1.168 g/cm3

Trademark

D-Sung

Transport Package

Negotiable

Specification

99%

Origin

Xi′an Shaanxi

Model NO.

D-Sung Levetiracetam

Product Name

Levetiracetam

Name

Levetiracetam Powder

Appearance

White Powder

Color

White

Store

Cool and Dry

Grade

Pharmaceutical Grade

Assay

HPLC 99%

Application

Anthelmintics

Specific

COA

Test Method

HPLC

Shelf Life

2 Years

CAS No.

102767-28-2

Molecular Formual

C8h14n2o2

Melting Point

118-119 C

Density

1.168 g/cm3

Trademark

D-Sung

Transport Package

Negotiable

Specification

99%

Origin

Xi′an Shaanxi

Product Desciption

99% Purity Anti-Epileptic Levetiracetam Pharmaceutical Raw Material Levetiracetam Powder Capsule Levetiracetam

Products:	Levetiracetame
CAS#:	102767-28-2
Molecular Formula:	C8H14N2O2
Molecular Weight:	170.21
Assay:	0.99
Appearance:	White powder

Levetiracetam, alias levanteracetam, levitestat, levetiracetam, is a white crystalline powder chemical. Chemical name (S) -α-ethyl-2-oxo-1-pyrrolidine acetamide, molecular formula C8H14N2O2, molecular weight of 170.20900. Levetiracetam as antiepileptic drugs, clinically mainly for adults and children over the age of 4 epilepsy partial seizures plus treatment.

Levetiracetam, marketed under the trade names Keppra among others, is a medication used to treat epilepsy. It is used for partial onset, myoclonic, or tonic-clonic seizures. It is the S-enantiomer of etiracetam. Levetiracetam is available by mouth in two forms: immediate release and extended release.[3] It is also available by injection. An immediate release tablet has been available as a generic in the United States since November 2008, and in the UK since 2011. The United States patent for the extended release tablet will expire on September 17, 2028. It was initially patented by UCB Pharma.